Related Experiment Video

Updated: Aug 10, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference

Momoko Otaki1, Kiyonao Sada, Hiroyasu Kadoya

  • 1Division of Microbiology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.

Antiviral Research
|March 15, 2006
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) is a fatal measles complication. Researchers found that small interfering RNAs (siRNAs) targeting the measles virus L mRNA can effectively inhibit viral replication, offering a potential new treatment strategy for SSPE.

Area of Science:

  • Virology
  • Molecular Biology
  • Neuroscience

Background:

  • Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological disease resulting from persistent measles virus (MeV) infection.
  • Current combination therapies offer limited survival benefits, highlighting the urgent need for novel treatment strategies.

Purpose of the Study:

  • To investigate the potential of RNA interference (RNAi) using small interfering RNAs (siRNAs) to inhibit MeV and SSPE virus replication.
  • To evaluate the efficacy of siRNAs targeting the L mRNA of MeV as a therapeutic approach for SSPE.

Main Methods:

  • Utilized synthetic siRNAs and expression plasmids (pcPUR+U6i) to generate siRNAs targeting the L mRNA of MeV.
  • Assessed the inhibitory effect of siRNAs on the replication of both MeV and the SSPE virus.
  • Evaluated the cytotoxic effects of the developed siRNAs.

Main Results:

  • siRNAs targeting MeV L mRNA effectively and specifically inhibited the replication of both MeV and SSPE virus.
  • No cytotoxic effects were observed with the tested siRNAs.
  • The L protein, a key component of the viral RNA-dependent RNA polymerase, was identified as a promising target due to its essential role in viral replication.

Conclusions:

  • The developed siRNAs targeting MeV L mRNA demonstrate significant potential as a therapeutic candidate for treating SSPE.
  • RNAi offers a promising strategy for developing new treatments against MeV-induced neurological disorders like SSPE.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...